{"title":"Synthesis of quinoxalines and assessment of their inhibitory effects against human non-small-cell lung cancer cells","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA04453C","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA04453C\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,28659-28668<br /><b>DOI</b>: 10.1039/D4RA04453C, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png\" alt=\"Creative Commons Licence\" /></a>Â  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\">Creative Commons Attribution-NonCommercial 3.0 Unported Licence.</a></div><div>Jia-Hua Liang, Shu-Tse Cho, Tzenge-Lien Shih, Jih-Jung Chen<br />Twenty-six quinoxalin derivatives were synthesized to assess their biological activities against human non-small-cell lung cancer cells (A549 cells). Among them, compound <strong>4m</strong> exhibited the most potent inhibitory activity against A549 cells.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"9f6db5eb3c193be31fb92e1d5bf4020298cc59b3fc70d850a67bde3f437b8cc7","category":"Environment"}